                                                                                         DAILY NATION, WEDNESDAY, APRIL 26, 2000                                                                                                    25
    21st AFRICAN HEALTH SCIENCIES CONGRESS & 21st KEMRI ANNIVERSARY                                                                                                                                SUPPLEMENT
                                                                                                                                                                                                  Institute has shown that cereal
                                      21 years of contributions to                                                                                                                                The pioneering work in Kenya by
                                                                                                                                                                                                  the research scientists of the
                                                                                                                                                                                                  based Oral Rehydration Salts (ORS)
                                                                                                                                                                                                  are just as effective as the standard
                                                                                                                                                                                                  some training, mothers can now use
                                      national and global health                                                                                                                                  factory produced ones in the
                                                                                                                                                                                                  treatment of diarrhoea. Thus, with
                                                                                                                                                                                                  these commonly available cereals
 Through its various research                                                                                                                                                                     like sorghum, millet or maize in·
 programmes, KEMRI has been in the forefront in                                                                                                                                                   their kitchens to prepare ORS to
 finding better ways for the control and treatment                                                                                                                                  treat diarrhoea at home when it starts.
 of diseases of public health importance in Kenya
 and in Africa.                                                                                                                                                                     Leprosy
    Research findings emanating from KEMRI's                                                                                                                                        The Institute has'investigated the WHO
 work are now being applied in the management                                                                                                                                       recommended multi-drug therapy, which
       ontrol of diseases and other health problems                                                                                                                                 combines three drugs, and th" results have
 in Kenya and elsewhere. The following are some of                                                                                                                                  shown that this therapy is effective in Kenya
 the Institute's achievements in its contribution to                                                                                                                                and that depending on the severity of the
 national and global health.                                                                                                                                                        disease, patients can be .completely cured
                                                                                                                                                                                    between 6 and 36 months. Results of a study to
 HIV/AIDS                                                                                                                                                                           develop an improved and a cheaper treatment
 KEMRI's contribution in HIV studies goes back to                                                                                                                                   schedule are promising.
 the early days when the first case of AIDS was
 diagnosed in the country. The first national survey of                                                                                                                             Traditional Medicine
 HIV infection in Kenya was conducted from the                                                                                                                                         Traditional medicine research has seen the
 Institute's Centre for Microbiology Research. In                                                                                                                                   launching of multi-disciplinary teams which
 those early days, KEMRI participated in the training                                                                                                                              collaborate with traditional doctors. Research at
 of Ministry of Health personnel in diagnosis and                                                                                                                                  the Institute has endeavored to develop a
 screening of blood for HIV.                                                                                                                                                       scientific rationale for incorporating traditional
    Scientists in the Institute pioneered the                                                                                                                                      medical practices into the modem health care
 investigation oflow-dose sublingual interferon alpha                                                                                                                               delivery system.
 for the management of AIDS. So far there is                                                                                                                                       Usefultz¢itional medicines for asthma,
overwhelming evidence that when this drug is given                                                                                                                                 epilepsY;~etes,      mild hypertension, gout and
in combination with other anti-infective drugs, very                                                                                                                               malaria haVfteeri identified and these form a
 significant improvement of the patient's health can be                                                                                                                            good foundation for future drug research in
achieved.                                                                                                                                                                          Kenya. Furthermore, the Institute's research has
    Drugs that are currently being tested or developed                                                                                                                             brought public awareness that has reduced the
at the Institute include Viron50 (a cocktail that             JICA President Mr Kensuke Yanagiya (second from left) observers keenly as Ms Magdalene Kinyanjui                     indiscriminate use ofhatmful herbal medicines.
includes interferon alpha), VIUSID (a nutritional                    explains a point in the immunology laboratory of the Centre for Biotechnology and Research                    International Recognition for the Institute's
product) and 1,2,4-trioxolane derivative.                                                                         Development.                                                     Capacity
    KEMRI has the only P3 level biosafety laboratory          growing the parasite in the laboratory for drug                                                                      he Institute's research output over the y~ars ha~
in the East and Central African region. The facility                                                                    In leishmaniasis, the Centre for Biotechnology
                                                              sensitivity testing.                                                                                               . given it regional and worldwide recogntlOn, WIth
makes it possible to carry out studies on the local                                                                     Research and Development (CBRD) contributed to             various departments being given mandates to
strains ofHIV.                                                Bilharzia                                       .         the development of a simple diagnostic test known as       provide leadership in their specific disciplines.
In a major development, the Institute collaborated            In its studies on urinary bilharzia, the Institute has    the Direct Agglutination Test.                             The Institute's Centre for Virus Research has
with JICA in developing an easy to use diagnostic kit         managed to reduce the prevalence by 60 per cent              The centre also maintains the only sandfly colony       established the infrastructure for diagnosis of
known as the Particle Agglutination. The advantages           in the areas of study, especially in the Coast            in sub-Sahara, an invaluable resource for any research     haemorrhagic fevers, The centre diagnosed the.
of this kit are that its reagents are produced locally, it                                                              work in leishmaniasis.
                                                              Province. This has been achieved mainly through                                                                      outbreak of yellow fever and Rift Valley feve~ m
does not require electricity, can test many samples at        mass chemotherapy and public health education,               With the support of the World Health Organization,      the early 90s, and has since then played a leadmg
the same time, and the results can be read visually
with the naked eye.                                             The results have been better living standards         scientists at the CBRD are carrying out studies that         role in establishing an active surveillance system
                                                              and enhanced performance among schoolchildren.          have shown prospects for development of a vaccine            for viral haemorrhagic fever.
The focus now is on public health and policy issues
in the control ofHIV/AIDS.                                                                                            against leishmaniasis, which would be a big step in          CVR provides the laboratory back-up for           .
                                                                                                                      controlling the disease,                                     evaluation of vaccines used in the country, and IS
                                                              Tuberculosis                                                                                                         participating in polio and measles eradication
Malaria
                                                              The Institute's Centre for Respiratory Diseases         Diarrhoea                                                    surveillance.
Drug studies on the viability of anti-malaria] drugs          Research (CRDR) played a central role in
such as quinine, quinidine, halofantrine, fansidar and
                                                              research leading to the adoption of the short
mefloquine have been carried out in the centre.
                                                              course chemotherapy for treatment of tuberculosis
The Institute played the central role in establishing
                                                              in 1993. This treatment course shortened the
resistance patterns to chloroquine in the country.
                                                              duration ofTB treatment to 6 months from 18
This resulted in the change in the country's policy
                                                              months, thus increasing the compliance to
shift from chloroquine as first-line treatment of             treatment.
malaria. Current studies are showing cases of
                                                                 Research work at the centre also demonstrated
resistance to fansidar, which was the alternative to
chloroquine.                                                  for the first time in Kenya the association between
                                                              HIV and the rise in cases ofTB. HIV is now
  In collaboration with the Wellcome Trust Research
                                                              known to be the single most important risk factor
Laboratories, the Institute has developed a new               for TB in Kenya.
combination drug known as Lap Dap, which has less
chances of developing resistance. Lap Dap will be a              The centre also documented the fact that severe
                                                              skin reactions are associated with the use of
vital tool in Africa for treatment of fansidar-resistant
parasites.                                                    thiacetazone in treatment of HIV-associated TB.
                                                              As a result, the government has set a policy that
  The Institute has also developed technologies for
predicting anti-malarial failure or success, which are        HIV positive TB patients should be treated with
                                                              TB drugs that excludes thiacetazone.
proving useful in formulation of measures to curb
drug resistance.                                              Hepatitis
  KEMRI's Centre for Geographic Medicine
                                                              Following a pilot hepatitis B immunisation project
Research is an internationally-recognised site for            carried out by KEMRI's Centre for Virus
malaria research work. In fact, it is the single most
important producer of research on malaria in Africa.          Research (CVR) in 1990, the Ministry of Health
                                                              integrated the hepatitis B vaccine into the
  Studies on severe malaria carried out from the                                                                         ICEA ...
                                                              expanded programme on immunisation (KEPI).
centre provided the basis for WHO international
                                                              Hepatitis B is known as the number one cause of
guidelines on recognition and management o~s<?vere
malaria in children. Research work on malana 111              liver cancer among the male population in the
                                                                 In collaboration with JICA, the centre has
                                                              country .                                                                                                                                                                   '.
pregnant women also led the gov~rnment. to adopt the
policy of intermittent treatment With fansldar to .
                                                              developed a kit for screening blood for hepatitis,        a total
are considering adopting the policy as a means to
reduce severe anaemia in pregnancy. Other countries
                                                              thus ensuring safe blood for transfusion. The kit
                                                              is already available at the provincial hospitals, and
reducing comp]icatio?s of childb!rt!l.
   The Kilifi centre pIOneered tra1l1mgof shopkeepers         personnel in those hospitals have been trained in         quality service
                                                              using the kit.
 training in management of fever.s in rural                                                                             •
                                                                                                                        Insurance
 communities, and the approach ISattractmg                       Research scientists at the Institute developed
 international interest.                                      specialized tissue typing methods for matching
 Kilifi was one of the three African centres that carried     kidney donor and recipient, and this technique
 out first studies on the Chinese herbal drug known as        was used in 1985 in the first kidney                      company for
 Qinghasao for treatment of ma~aria.. The centre              transplantation surgery at the Kenyatta National
 participated in large-scale studies of Impregnated.          Hospital. At the moment, we have employed the            .all classes of
                                                              transplantation and paternity purposes.      There
   ed-nets which showed that the nets have potential          more accurate DNA techniques for both
    r redu~ing hospital admissions for malaria by about                                                                 •
                                                                                                                        Insurance.
 40%.                                                         are plans to establish the DNA typing facilities for
     Apart from its research activities" the centre plays a   forensic work.
 crucial role in providing health servIces for patients
 visiting the Kilifi Distri~t Hospi~al. The centre            Leishmaniasis
 provides first class medical servIce for the over 4000       Among the outstanding research results from the
 children admitted to the hospital every year, and            KEMRI have been the development of the current
 makes no distinction between children in research            recommended treatment for visceral
 projects and the rest.                                       leishmaniasis. The dosage now being used in the
     In vaccine studies, research work on the centre has      region was developed following research at the
 characterised several candidate antigens that have           Institute's Centre for Clicial Research (CCR)
potential for encompassing the entire life-cycle of the       wards.                                                    INSURANCE COMPANY OF EAST AFRICA LTD.
malaria parasite. Such a vaccine has undergone                   The current method of diagnosis for kala-azar,
laboratory studies and prospects are bright for clinical      known as the splenic aspiration technique, was               ICEA Building, Kenyatta Avenue,
                                                              also developed here. The technique has little                                                                Maritime Centre Archbishop           Makario's Rd.,
trials.                                                                                                                    P. O. Box 46143,
                                                              potential for complications and is recommended                                                               P. O. Box 90101,
    In collaboration with the Centres for Diseases                                                                         Tel: 221652,340365
                                                              the world over by the WHO.                                                                                   Tel: 011-224646/224647/224648
Control, a synthetic vaccine has been developed and                                                                        Fax: 338089
                                                                 CCR was also involved in the WHO                                                                         Fax: 011-311574
 has already reached the field tria] stage.                                                                                                                              ~.
 The Institute has also developed an improved system          multi-centre trial of a drug known as Ambisome,              E-mail: hof@icea.co.ke
 of storing blood from field sites to the laboratory.         which is used in the treatment of Kenyan visceral
This method is crucial to studies that depend on              leishmaniasis.                                                                             Website: www.icea.co.ke
Page 


-------------------Trial Version-----------------------

Convert PDF to Text Desktop Software.

Copyright Convertpdftotext.net 2014.

To remove these lines, please activate your software from http://www.convertpdftotext.net/buynow.htm

-------------------------------------------------------
